45 related articles for article (PubMed ID: 2385295)
1. [Application of recombinant vaccinia vaccine; a recommendation from the Public Health Council].
Dekking F
Ned Tijdschr Geneeskd; 1990 Jun; 134(25):1204-5. PubMed ID: 2385295
[No Abstract] [Full Text] [Related]
2. Poxviruses as vaccine vectors.
Pastoret PP; Vanderplasschen A
Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):343-55. PubMed ID: 12818621
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
[TBL] [Abstract][Full Text] [Related]
4. Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.
Hu SL; Fultz PN; McClure HM; Eichberg JW; Thomas EK; Zarling J; Singhal MC; Kosowski SG; Swenson RB; Anderson DC
Nature; 1987 Aug 20-26; 328(6132):721-3. PubMed ID: 3475581
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of vaccinia virus in glioma model.
Timiryasova TM; Li J; Chen B; Chong D; Langridge WH; Gridley DS; Fodor I
Oncol Res; 1999; 11(3):133-44. PubMed ID: 10527073
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen.
Schütz A; Oertli D; Marti WR; Noppen C; Padovan E; Spagnoli GC; Heberer M; Zajac P
Cancer Gene Ther; 2001 Sep; 8(9):655-61. PubMed ID: 11593334
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in colorectal cancer.
Wallack MK
Mo Med; 1981 Jan; 78(1):23-5. PubMed ID: 7219405
[No Abstract] [Full Text] [Related]
8. The effect of attenuated vaccinia virus AS strain on multiple myeloma; a case report.
Kawa A; Arakawa S
Jpn J Exp Med; 1987 Feb; 57(1):79-81. PubMed ID: 3626096
[TBL] [Abstract][Full Text] [Related]
9. Antigenic properties of vaccinia virus and of the virus recombinant strains expressing heterologous genes.
Chelyapov NV; Antonova TP; Yanova NN; Chernos VI
Acta Virol; 1988 Sep; 32(5):409-16. PubMed ID: 2904735
[TBL] [Abstract][Full Text] [Related]
10. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection.
Ramshaw IA; Andrew ME; Phillips SM; Boyle DB; Coupar BE
Nature; 1987 Oct 8-14; 329(6139):545-6. PubMed ID: 3498904
[TBL] [Abstract][Full Text] [Related]
11. Immunisation of cattle with a recombinant togavirus-vaccinia virus strain.
Franke CA; Berry ES; Smith AW; Hruby DE
Res Vet Sci; 1985 Jul; 39(1):113-5. PubMed ID: 3862196
[TBL] [Abstract][Full Text] [Related]
12. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
Lodmell DL; Esposito JJ; Ewalt LC
Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
[TBL] [Abstract][Full Text] [Related]
13. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines.
NAM JH; BANG HS; CHO HW; CHUNG YH
Acta Virol; 2007; 51(2):125-30. PubMed ID: 17900219
[TBL] [Abstract][Full Text] [Related]
14. Versatile vaccine.
Newmark P
Microbiol Sci; 1984 Apr; 1(1):25. PubMed ID: 6444091
[No Abstract] [Full Text] [Related]
15. Antitumor efficacy of two kinds of tumor vaccine modified with vaccinia virus.
Ito T; Okabayashi M; Osada Y; Wakamiya N; Kato S
In Vivo; 1988; 2(5):325-9. PubMed ID: 2979853
[TBL] [Abstract][Full Text] [Related]
16. Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.
Chen CH; Wang TL; Ji H; Hung CF; Pardoll DM; Cheng WF; Ling M; Wu TC
Gene Ther; 2001 Jan; 8(2):128-38. PubMed ID: 11313782
[TBL] [Abstract][Full Text] [Related]
17. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
[TBL] [Abstract][Full Text] [Related]
18. Applications of recombinant vaccinia virus for veterinary vaccines.
Yilma T
Dev Biol Stand; 1994; 82():201-9. PubMed ID: 7958475
[No Abstract] [Full Text] [Related]
19. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E
Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675
[TBL] [Abstract][Full Text] [Related]
20. Successful vaccination with a polyvalent live vector despite existing immunity to an expressed antigen.
Flexner C; Murphy BR; Rooney JF; Wohlenberg C; Yuferov V; Notkins AL; Moss B
Nature; 1988 Sep; 335(6187):259-62. PubMed ID: 2842693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
